Osimertinib in Patients With Non-Small Cell Lung Cancer and Uncommon EGFR Mutations-Chasing Unicorns?

被引：1
|
作者：
Wang, Victoria E. [1 ,2 ,4 ]
Gainor, Justin F. [3 ]
机构：
[1] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
[2] Univ Calif San Francisco, Helen Diller Comprehens Canc Ctr, San Francisco, CA USA
[3] Massachusetts Gen Hosp, Dept Med, Boston, MA USA
[4] 1825 Fourth St, Sixth Floor, San Francisco, CA 94158 USA
来源：
JAMA ONCOLOGY | 2024年 / 10卷 / 01期
关键词：
AFATINIB;
D O I：
10.1001/jamaoncol.2023.5004
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：52 / 53
页数：2
相关论文
共 50 条
  • [1] Uncommon EGFR mutations in advanced non-small cell lung cancer
    O'Kane, Grainne M.
    Bradbury, Penelope A.
    Feld, Ronald
    Leighl, Natasha B.
    Liu, Geoffrey
    Pisters, Katherine -M.
    Kamel-Reid, Suzanne
    Tsao, Ming S.
    Shepherd, Frances A.
    LUNG CANCER, 2017, 109 : 137 - 144
  • [2] A comprehensive review of uncommon EGFR mutations in patients with non-small cell lung cancer
    Tu, Hai-Yan
    Ke, E-E
    Yang, Jin-Ji
    Sun, Yue-Li
    Yan, Hong-Hong
    Zheng, Ming-Ying
    Bai, Xiao-Yan
    Wang, Zhen
    Su, Jian
    Chen, Zhi-Hong
    Zhang, Xu-Chao
    Dong, Zhong-Yi
    Wu, Si-Pei
    Jiang, Ben-Yuan
    Chen, Hua-Jun
    Wang, Bin-Chao
    Xu, Chong-Rui
    Zhou, Qing
    Mei, Ping
    Luo, Dong-Lan
    Zhong, Wen-zhao
    Yang, Xue-Ning
    Wu, Yi-Long
    LUNG CANCER, 2017, 114 : 96 - 102
  • [3] Clinical Outcomes of Afatinib Versus Osimertinib in Patients With Non-Small Cell Lung Cancer With Uncommon EGFR Mutations: A Pooled Analysis
    Wang, Chunsheng
    Zhao, Kewei
    Hu, Shanliang
    Dong, Wei
    Gong, Yan
    Xie, Conghua
    ONCOLOGIST, 2023, 28 (06): : E397 - E405
  • [4] Current management of uncommon EGFR mutations in non-small cell lung cancer
    Trinh, Jonathan Q.
    Abughanimeh, Omar
    CURRENT PROBLEMS IN CANCER, 2024, 49
  • [5] Osimertinib rechallenge in advanced EGFR non-small cell lung cancer patients
    Uy, Natalie F.
    Tratt, Micah
    Eaton, Keith D.
    Santana-Davila, Rafael
    Baik, Christina S.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [6] From Rarity to Reality: Osimertinib's Promising Horizon in Treating Uncommon EGFR Mutations in Non-Small Cell Lung Cancer
    Fukuda, Akito
    Okuma, Yusuke
    CLINICAL CANCER RESEARCH, 2024, 30 (15) : 3128 - 3136
  • [7] A case report: Response to Osimertinib in non-small cell lung cancer patient with uncommon EGFR mutation
    Craig, Daniel J.
    Kahlon, Navkirat K.
    Hamouda, Danae M.
    CURRENT PROBLEMS IN CANCER: CASE REPORTS, 2022, 8
  • [8] Osimertinib for uncommon EGFR mutations: herding UNICORNs in a field of horses
    Dougherty, Sean C.
    Gentzler, Ryan D.
    TRANSLATIONAL CANCER RESEARCH, 2025, 14 (02) : 670 - 675
  • [9] DETECTING EGFR MUTATIONS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER
    Hammoudeh, Z. A.
    Antonova, O.
    Staneva, R.
    Nikolova, D.
    Kyuchukov, Y.
    Penev, A.
    Mintchev, T.
    Koleva, V
    Hadjidekova, S.
    Toncheva, D.
    BALKAN JOURNAL OF MEDICAL GENETICS, 2018, 21 (01) : 13 - 17
  • [10] Treatment of uncommon EGFR mutations in non-small cell lung cancer: new evidence and treatment
    Zhang, Tianli
    Wan, Bing
    Zhao, Yuan
    Li, Chuling
    Liu, Hongbing
    Lv, Tangfeng
    Zhan, Ping
    Song, Yong
    TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 (03) : 302 - 316
12345